Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Royalty Pharma News
RPRX
ROYALTY PHARMA PLC
25.92
+0.15%
RPRX
ROYALTY PHARMA PLC
25.92
+0.15%
Articles
Latest stories
Agios Pharma sells 15% royalty rights of Servier's vorasidenib for $905M upon FDA approval
Authors
7
1 month
Economics
Business
Agios Sells Royalty Rights to Royalty Pharma for $905M
Authors
7
1 month
Bio
Science
Cytokinetics, Royalty Pharma Announce $575M Funding for Aficamten; 9.8M Shares Offered, 14.9% Pre-Market Drop
Authors
10
1 month
Bio
Science
Cytokinetics Sells Heart Drug Share to Royalty Pharma for $575 Million, Buyout Hopes Dim
Authors
8
1 month
Bio
Science
Cytokinetics Secures $575M Deal with Royalty Pharma, Plans New Phase III Trials for Aficamten and Omecamtiv
Authors
15
1 month
Bio
Science
Novartis Buys MorphoSys at EUR 68.00/Share, 85% Premium in Landmark $3B Deal
Authors
8
5 months
Bio
Science
Previous
Next